SEC Form 4 · accession 0001231919-26-000869
Latigo Biotherapeutics, Inc. · LTGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Andrew J. Schwab
10% Owner
Kush Parmar
10% Owner
5AM Ventures VI, L.P.
10% Owner
5AM Partners VI, LLC
10% Owner
5AM Opportunities II, L.P.
10% Owner
5AM Opportunities II (GP), LLC
10% Owner
Period of report
Aug 10, 2026
Accepted (ET)
Aug 12, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002056611
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 10, 2026 | C | 4,975,543 | — | A | 4,975,543 | I | By 5AM Ventures VI, L.P. |
| Common StockF1,F3 | Aug 10, 2026 | C | 2,350,419 | — | A | 2,350,419 | I | By 5AM Opportunities II, L.P. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF2,F1 | — | Aug 10, 2026 | C | 3,152,305 | D | — | — | Common Stock | 3,152,305 | 0 | I |
| Series A-2 Preferred StockF2,F1 | — | Aug 10, 2026 | C | 1,823,238 | D | — | — | Common Stock | 1,823,238 | 0 | I |
| Series A-2 Preferred StockF3,F1 | — | Aug 10, 2026 | C | 866,018 | D | — | — | Common Stock | 866,018 | 0 | I |
| Series B Preferred StockF3,F1 | — | Aug 10, 2026 | C | 1,484,401 | D | — | — | Common Stock | 1,484,401 | 0 | I |
Explanation of responses
- F1Each share of Series A Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis. The Series A Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock had no expiration date.
- F2The securities are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar, and Mr. Schwab disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein.
- F3The securities are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the general partner of Opportunities II and may be deemed to have sole investment and voting power over the securities held by Opportunities II. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Opportunities II GP and may be deemed to have shared voting and investment power over the securities beneficially owned by Opportunities II. Each of Opportunities II GP, Dr. Parmar, and Mr. Schwab disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein.